Efficacy & Safety Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder (TD)
Status:
Completed
Trial end date:
2014-03-12
Target enrollment:
Participant gender:
Summary
The goal of the current trial is to determine efficacy and safety of once-weekly aripiprazole
in reducing Total Tic Severity (TTS) score in children and adolescents with Tourette's
Disorder.
Phase:
Phase 3
Details
Lead Sponsor:
Otsuka Pharmaceutical Development & Commercialization, Inc.